This project represents a continuation of Project 2 from the previous grant period of our ADRC. At the outset of that project, data from postmortem studies available on the rare group of individuals who carry mutations that cause early-onset familial Alzheimer's disease (eFAD) indicated that amyloid deposition in these carriers shared a final common pathway with late-onset sporadic Alzheimer's disease (LOAD). The unique advantage of in vivo amyloid imaging, is that it allows longitudinal studies on individuals beginning in the very earliest stages of the disease. By exploiting this capability, we demonstrated a dramatic difference in the timing and regional distribution of PiB retention in many subjects with several distinct eFAD mutations. At the earliest, presymptomatic stages, many mutation carriers show intense, focal Pittsburgh Compound-B (PiB) retention in the striatum and relatively little neocortical PiB retention. Furthermore, our unpublished data suggests that the amount of striatal amyloid may recede in the later stages of eFAD. It is important to fully understand the similarities and differences in the natural history of eFAD and LOAD. In this project, we propose to continue the first-ever amyloid imaging studies in presymptomatic eFAD and extend these studies to help understand the mechanistic and functional underpinnings of the striatal findings. First, we will take advantage of the valuable cohort of eFAD subjects we have assembled, to continue to document the natural history of amyloid deposition and begin to look for functional correlates by adding a measure of blood flow (arterial spin labeling or ASL) that we will be applying in separate LOAD studies. Second, we will recruit subjects between 21 and 30 years of age to determine how early this process may begin. Third, we will utilize neuropsychological tests chosen specifically to challenge striatal circuits in an attempt to uncover correlates of striatal amyloid in the otherwise asymptomatic mutation carriers. Fourth, we will perform detailed histological studies on a postmortem brain from a parent of one of the larger, extended PS1 families currently in our study to determine if the unusual pattern of PiB retention in this kindred is based on an atypical distribution of typical AB or on a typical distribution of atypical tertiary structures of AB.

Public Health Relevance

Answers to the questions posed by this study will help us understand the significance of amyloid deposition in non-demented individuals. If it becomes clear that pre-clinical amyloid depositions progresses to clinical AD with high frequency, then it will become important to identify and treat non-demented, amyloid-positive individuals. It will be important to identify the optimal time point to begin treatment, i.e. prior to the onset of clinical symptoms. It is at this early stage that anti-amyloid therapies will likely be most effective.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005133-30
Application #
8449134
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
30
Fiscal Year
2013
Total Cost
$170,365
Indirect Cost
$49,264
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lai, Dongbing; Xu, Huiping; Koller, Daniel et al. (2016) A MULTIVARIATE FINITE MIXTURE LATENT TRAJECTORY MODEL WITH APPLICATION TO DEMENTIA STUDIES. J Appl Stat 43:2503-2523
Raji, Cyrus A; Merrill, David A; Eyre, Harris et al. (2016) Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study. J Alzheimers Dis 52:719-29
Tosto, Giuseppe; Bird, Thomas D; Bennett, David A et al. (2016) The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol 73:1231-1237
Day, Gregory S; Musiek, Erik S; Roe, Catherine M et al. (2016) Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study. JAMA Neurol 73:1125-32
Ronquillo, Jay Geronimo; Baer, Merritt Rachel; Lester, William T (2016) Sex-specific patterns and differences in dementia and Alzheimer's disease using informatics approaches. J Women Aging 28:403-11
Kovacs, Gabor G; Ferrer, Isidro; Grinberg, Lea T et al. (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87-102
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-20
Ringman, John M; Monsell, Sarah; Ng, Denise W et al. (2016) Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. J Neuropathol Exp Neurol 75:284-90
Besser, Lilah M; Alosco, Michael L; Ramirez Gomez, Liliana et al. (2016) Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition. J Neuropathol Exp Neurol 75:955-962
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2016) Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development. Arch Gerontol Geriatr 65:231-8

Showing the most recent 10 out of 519 publications